This inventor holds 2 USPTO granted patents. Top assignee: Fujirebio Kabushiki Kaisha. Active years: 1987-1989.
Location History:
- Tokyo, JP (1987)
- Inagi, JP (1989)
Company Filing History:
Years Active: 1987-1989
Title: Teruo Kutsuma: Innovator in Pharmaceutical Chemistry
Introduction
Teruo Kutsuma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative approach to drug design.
Latest Patents
Kutsuma holds 2 patents that focus on alkylamide derivatives. His first patent involves alkylamide derivatives with H₂-receptor antagonistic properties. These compounds exhibit a strong antiulcer action, which is dependent on their histamine H₂-receptor antagonistic action and a cytoprotective effect on the gastric mucous membrane. His second patent pertains to antihypertensive 1,4-dihydropyridines, which are characterized by a conjugated ester. These 1,4-dihydropyridine derivatives are designed to have a hypotensive action that is effective over a long duration, allowing for a gradual decrease in blood pressure while maintaining low toxicity.
Career Highlights
Kutsuma is currently associated with Fujirebio Kabushiki Kaisha, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for various health issues, particularly in the realm of hypertension and gastric health.
Collaborations
Throughout his career, Kutsuma has collaborated with esteemed colleagues such as Hiroshi Ikawa and Yoshiaki Sato. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in pharmaceutical chemistry.
Conclusion
Teruo Kutsuma's contributions to the field of pharmaceutical chemistry are noteworthy, particularly through his innovative patents and collaborations. His work continues to impact the development of effective therapeutic compounds, showcasing the importance of innovation in healthcare.